Amnis Corporation has created a breakthrough technology for the multispectral imaging of cells in flow. Amnis' first product generates up to six simultaneous images of each cell in brightfield, darkfield, and multiple colors of fluorescence. These groundbreaking capabilities will allow Amnis' customers to perform multiparametric cellular assays to advance drug discovery and development, basic research, and clinical diagnostics.
